[28]–[30] Serum sCD163 was significantly elevated in patients with fulminant hepatic failure as compared with patients with hepatitis or healthy controls [31]; it was also reported to be a predictor of mortality for patients with acute liver failure [32]. This evidence concerns the gene CD163 and Hepatitis.